☆ 4.4 Review

The impact of COVID-19 in pregnancy: Part II. Vaccination to pregnant women

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2021)

Related references

Note: Only part of the references are listed.

Letter Obstetrics & Gynecology

COVID-19 Vaccination in Pregnancy: The Benefits Outweigh the Risks

Monica Chavan et al.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Pregnancy and viral infections: Mechanisms of fetal damage, diagnosis and prevention of neonatal adverse outcomes from cytomegalovirus to SARS-CoV-2 and Zika virus

Cinzia Auriti et al.

Summary: Viral infections during pregnancy can present risks to the fetus or newborn, with asymptomatic infants potentially experiencing worse outcomes at birth and potential long-term neurosensory issues. Maternal immune system adaptations during pregnancy play a crucial role in maintaining a balance between maternal immunity and fetal health, with viral infections disrupting this balance and leading to adverse outcomes for the fetus and newborn.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Sialylated autoantibodies involved in disease activity of rheumatoid arthritis

Fa-Kung Lee et al.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2021)

Add to Collection

Editorial Material Multidisciplinary Sciences

HOW COVID UNLOCKED THE POWER OF RNA

Elie Dolgin

Summary: This technology has the potential to revolutionize immunization efforts against diseases such as HIV, malaria, influenza, and more.

NATURE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Jordan R. Barrett et al.

Summary: The study demonstrates that a booster dose of ChAdOx1 nCoV-19 is safer and better tolerated than priming doses. The booster dose significantly enhances anti-spike neutralizing antibody titers and other functional antibody responses. These data support the two-dose vaccine regime currently being evaluated in phase 3 clinical trials.

NATURE MEDICINE (2021)

Add to Collection

Review Medicine, General & Internal

Maintaining Safety with SARS-CoV-2 Vaccines

Mariana C. Castells et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Obstetrics & Gynecology

Balancing risks: making decisions for maternal treatment without data on fetal safety

Howard Minkoff et al.

Summary: The balance between the rights of pregnant women and the protection of the fetus is challenged when treating maternal health risks for the fetus. Pregnant women should be supported in trying new interventions, and including pregnant individuals in clinical trials is a solution to avoid the dilemma of absent data.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Add to Collection

Article Obstetrics & Gynecology

Vaccines-safety in pregnancy

Mala Arora et al.

Summary: Vaccination during pregnancy is important for the health of both the mother and newborn, with safe vaccines including tetanus toxoid, Tdap, and Flu vaccines; high-risk women should receive specific vaccines such as hepatitis A and B; postpartum women should consider HPV vaccination and other necessary vaccines.

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2021)

Add to Collection

News Item Medicine, General & Internal

Pregnant People's Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications

Rita Rubin

Summary: Research shows that administering COVID-19 vaccines to pregnant individuals is safe and effective.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Editorial Material Medicine, General & Internal

COVID-19 Vaccination in Pregnant and Lactating Women

Emily H. Adhikari et al.

Summary: Shared decision-making is crucial when counseling pregnant and nursing women about the unstudied benefits and risks of COVID-19 vaccination. Rigorously designed studies with real-time, proactive data collection are needed to establish evidence quickly about the safety of coronavirus vaccines in mothers and their infants.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Medicine, General & Internal

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey et al.

Summary: The AZD1222 vaccine has been approved for emergency use in the UK with an interval of 4-12 weeks between doses. Analysis shows that the vaccine is efficacious with two doses and provides immunoprotection after the first dose before the second dose is administered.

LANCET (2021)

Add to Collection

Article Obstetrics & Gynecology

Current status of pertussis vaccination during pregnancy and influencing factors in Korea

Chaewon Kim et al.

Summary: The study in Korea found that 67% of pregnant women received pertussis vaccination during pregnancy, but 27.9% did not receive information about pertussis and vaccination. Independent influencing factors for maternal pertussis vaccination included being informed, being informed by OBGYN doctors, and residing in metropolitan areas. Around 56.3% of maternity HCPs routinely recommended pertussis vaccination, with factors affecting routine recommendation being awareness of guidelines and personal pertussis vaccination history within 10 years.

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2021)

Add to Collection

Article Obstetrics & Gynecology

Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study

Kathryn J. Gray et al.

Summary: The study found that pregnant and lactating women had equivalent antibody titers after receiving the coronavirus disease 2019 mRNA vaccine compared to nonpregnant women, and these titers were higher than those induced by natural infection. Vaccine-induced antibodies were present in umbilical cord blood and breastmilk samples, transferring immunity to neonates through placenta and breastmilk.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Add to Collection

Article Obstetrics & Gynecology

Vaccination in pregnancy: Challenges and evidence-based solutions

Eliana Castillo et al.

Summary: Vaccination in pregnancy (VIP) offers dual benefits for mothers and babies, but uptake rates are low in many countries, with vaccine hesitancy being a major issue. Lack of provider recommendations, safety concerns, and access limitations are the main barriers to VIP.

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Novel approaches for vaccine development

Makda S. Gebre et al.

Summary: Vaccines are crucial for global health, with traditional methods being successful in many cases but facing challenges such as persistent infections and emerging pathogens. Novel technologies like nucleic acid and viral vector vaccines have the potential to revolutionize vaccine development.

CELL (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The multifaceted roles of breast milk antibodies

Caroline Atyeo et al.

Summary: Neonates rely on maternal antibodies transferred via the placenta and breast milk for protection, with breast milk antibodies playing important roles in preventing infections, supporting the selection of commensals, and promoting tolerizing immunity.

CELL (2021)

Add to Collection

Article Immunology

Adverse Pregnancy Outcomes, Maternal Complications, and Severe Illness Among US Delivery Hospitalizations With and Without a Coronavirus Disease 2019 (COVID-19) Diagnosis

Jean Y. Ko et al.

Summary: This study explored the association between COVID-19 at delivery and adverse pregnancy outcomes, finding increased risks for several severe complications. Discharge status was not affected by COVID-19 diagnosis, and there were no significant differences in risk for complications or severe illness by race/ethnicity.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Microbiology

COVID-19: vaccination problems

Harald Brussow

Summary: This minireview addresses various issues related to vaccine development, regulation, ethics, efficacy, and coverage of variant viruses. The article discusses serious adverse effects observed with adenovirus vectored vaccines and mRNA vaccines in mass vaccination campaigns, as well as ethical problems and specific vaccination issues. Strategies to increase vaccine acceptance in the population are briefly mentioned.

ENVIRONMENTAL MICROBIOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women

Ai-ris Y. Collier et al.

Summary: This study assessed the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women, as well as the responses against emerging SARS-CoV-2 variants. The results showed that pregnant, lactating, and nonpregnant women developed antibody and T-cell responses following vaccination, with antibodies transferred to infant cord blood and breast milk. While antibody titers against the B.1.1.7 and B.1.351 variants were reduced, T-cell responses remained against the viral variants.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Medicine, General & Internal

Pandemic analysis of infection and death correlated with genomic open reading frame 10 mutation in severe acute respiratory syndrome coronavirus 2 victims

De-Ming Yang et al.

Summary: The study analyzed mutations in the Orf10 protein of SARS-CoV-2 patients, finding varying mutation rates in different regions, with higher rates in A8 and V30. The numbers of COVID-19 patients are correlated to the death numbers, but not with the death rates, and the A8, I13, and V30 sites in the Orf10 sequence show high mutation rates.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2021)

Add to Collection

Article Medicine, General & Internal

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

Tom T. Shimabukuro et al.

Summary: Preliminary data indicates that there are no obvious safety signals among pregnant women who received mRNA Covid-19 vaccines, but more data is needed for further confirmation. Adverse reactions such as injection-site pain were reported more frequently in pregnant women, but most pregnancies resulted in live births with some cases of preterm birth and small size for gestational age.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Obstetrics & Gynecology

Clinical and obstetric characteristics of pregnant women with Covid-19: A case series study on 26 patients

Masoumeh Abedzadeh-Kalahroudi et al.

Summary: The clinical characteristics and outcomes of pregnant women with COVID-19 are similar to the general population. Common outcomes include an increased rate of preterm delivery and cesarean section in mothers, while premature birth and low birth weight are the most prevalent outcomes in newborns. Careful monitoring of pregnant women with COVID-19 is recommended.

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2021)

Add to Collection

Review Obstetrics & Gynecology

Relationship of COVID-19 with pregnancy

Umme Salma

Summary: The COVID-19 pandemic poses risks and challenges to pregnant women and newborns, requiring close monitoring, isolation, and precautionary measures. There is still insufficient evidence on the vertical transmission and management of COVID-19 during pregnancy, necessitating further research and practice.

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2021)

Add to Collection

Review Immunology

SARS-CoV-2 Vaccination During Pregnancy: A Complex Decision

Elizabeth Wenqian Wang et al.

Summary: Despite the lack of data on vaccine safety in pregnant and breastfeeding individuals, the known risks of COVID-19 during pregnancy likely outweigh the potential risks of SARS-CoV-2 vaccines, which have demonstrated reassuring safety and efficacy profiles in nonpregnant populations.

OPEN FORUM INFECTIOUS DISEASES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2

Fatima Amanat et al.

Summary: After receiving the SARS-CoV-2 spike mRNA vaccine, individuals showed robust polyclonal antibody responses, with a majority of vaccine-induced antibodies lacking neutralizing activity. However, vaccine-induced RBD binding antibodies may offer substantial protection against viral variants carrying single E484K RBD mutations.

CELL (2021)

Add to Collection

Article Medicine, General & Internal

Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health Outcomes

Azar Mehrabadi et al.

Summary: Seasonal influenza vaccination during pregnancy was not significantly associated with adverse early childhood health outcomes among offspring. This population-based cohort study provides evidence on the safety of maternal influenza vaccination during pregnancy in relation to early childhood health outcomes in Nova Scotia, Canada.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Editorial Material Medicine, General & Internal

Realizing the Potential of Maternal Influenza Vaccination

Eduardo Azziz-Baumgartner et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Review Medicine, General & Internal

The impact of COVID-19 in pregnancy: Part I. Clinical presentations and untoward outcomes of pregnant women with COVID-19

Peng-Hui Wang et al.

Summary: Pregnant women infected with COVID-19 are at higher risk of developing severe illness, needing hospitalization and intensive care, and facing mortality compared to nonpregnant women or pregnant women without the infection. This poses challenges in service provision, prevention, and management, highlighting the urgent need for optimized strategies and guidelines.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2021)

Add to Collection

Article Multidisciplinary Sciences

Systems vaccinology of the BNT162b2 mRNA vaccine in humans

Prabhu S. Arunachalam et al.

Summary: The study found that vaccination with the Pfizer-BioNTech mRNA vaccine can induce immune responses against neutralizing antibodies and CD4, CD8 T cells of SARS-CoV-2. Booster vaccines can significantly enhance innate immune responses, and different innate pathways associated with CD8 T cells and neutralizing antibodies have been identified.

NATURE (2021)

Add to Collection

Article Medicine, General & Internal

Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine

Paul T. Heath et al.

Summary: The NVX-CoV2373 vaccine demonstrated an efficacy of 89.7% in a phase 3 trial with over 15,000 participants, with mild and transient reactogenicity. It showed high efficacy against the B.1.1.7 variant and a low incidence of adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Editorial Material Medicine, General & Internal

mRNA Covid-19 Vaccines in Pregnant Women

Laura E. Riley

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

News Item Multidisciplinary Sciences

'Landmark' African vaccine trial faces impasse

Jon Cohen

SCIENCE (2021)

Add to Collection

Article Obstetrics & Gynecology

Maternal and fetal outcomes of the pregnant woman with COVID-19 The first case report in Taiwan

Le-Ming Wang et al.

Summary: The case report describes the first case in Taiwan of a near-term pregnant woman infected with COVID-19. She was diagnosed at 36 gestational weeks, delivered a healthy baby via selective cesarean section at 38 weeks, and no evidence of in utero transmission was found.

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2021)

Add to Collection

Article Obstetrics & Gynecology

A symptomatic near-term pregnant woman recovered from SARS-CoV-2 infection

Szu-Ting Yang et al.

Summary: This case report describes the management of a pregnant woman with COVID-19 in the third trimester and successful delivery at term. The woman was diagnosed at 35 gestational weeks, required oxygen supplement and prednisolone therapy, and was discharged uneventfully at 37 weeks. The female baby was delivered via cesarean section at 38 weeks without contracting SARS-CoV-2, highlighting the importance of individualized decision making in the management of pregnant women with COVID-19.

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2021)

Add to Collection

Letter Pharmacology & Pharmacy

COVID-19 vaccines and pregnancy: What do we know?

Judith Cottin et al.

THERAPIE (2021)

Add to Collection

Article Acoustics

Short-term outcome of pregnant women vaccinated with BNT162b2 mRNA COVID-19 vaccine

S. Bookstein Peretz et al.

Summary: This observational study compared the immunogenicity and reactogenicity of the Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine between pregnant and non-pregnant women. The study found that pregnant women experienced similar rates of adverse effects following vaccination as non-pregnant women, with lower levels of SARS-CoV-2 IgG. The vaccine was effective in generating a humoral immune response in pregnant women, with no safety concerns identified.

ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2021)

Add to Collection

Review Immunology

Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis

Courtney Gidengil et al.

Summary: This systematic review of vaccine safety for children, adults, and pregnant women found few associations of vaccines with serious key adverse events, but rare events are challenging to study.

VACCINE (2021)

Add to Collection

Review Environmental Sciences

The Differences in Clinical Presentation, Management, and Prognosis of Laboratory-Confirmed COVID-19 between Pregnant and Non-Pregnant Women: A Systematic Review and Meta-Analysis

Durray Shahwar A. Khan et al.

Summary: Although non-pregnant women were more likely to experience clinical symptoms of COVID-19, pregnant women with COVID-19 had a higher requirement for ICU admission and invasive mechanical ventilation compared to non-pregnant women with COVID-19. More well-conducted studies are needed to draw definitive conclusions.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Add to Collection

Article Public, Environmental & Occupational Health

COVID-19 Vaccination Coverage Among Pregnant Women During Pregnancy — Eight Integrated Health Care Organizations, United States, December 14, 2020–May 8, 2021

Hilda Razzaghi et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Immunology

Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: A Meta-Analysis

Haoyue Cheng et al.

Summary: The study found that all COVID-19 vaccines have good preventive effects on COVID-19, with mRNA vaccines being the most effective and inactivated vaccines being the least effective. In terms of safety, the risk of overall adverse events increases after vaccination, but the risk of local and systemic adverse events decreases after the second injection.

VACCINES (2021)

Add to Collection

Article Medicine, Research & Experimental

Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine

Ofer Beharier et al.

Summary: The study demonstrates that the BNT162b2 mRNA vaccine induces a strong maternal IgG response that crosses the placenta barrier to reach fetal titers within 15 days of the first dose. The transfer ratio of anti-COVID-19 antibodies from mother to neonate differs between vaccination and infection groups, with lower IgG transfer ratio for third-trimester compared to second-trimester infection. Additionally, fetal IgM response was only detected in neonates from the infected group.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Review Health Care Sciences & Services

Management and Prevention of COVID-19 in Pregnancy and Pandemic Obstetric Care: A Review of Current Practices

Argyro Pountoukidou et al.

Summary: This study aims to summarize up-to-date information about the prevention and management of suspected/confirmed SARS-CoV-2 infection in obstetric patients. Recommendations include postponing non-urgent appointments, minimizing exposure to the virus with adjusted ultrasound schedules, and discussing vaccination. In case of infection, glucocorticoids may be considered for critically ill pregnant women, and precautions should be taken to reduce aerosolization and hemorrhage during labor.

HEALTHCARE (2021)

Add to Collection

Review Medicine, General & Internal

Aberrant sialylation in ovarian cancers

Wen-Ling Lee et al.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2020)

Add to Collection

Article Obstetrics & Gynecology

Factors affecting pregnant women's decisions regarding prenatal pertussis vaccination: A decision-making study in the nationwide Prenatal Pertussis Immunization Program in Taiwan

Wen-Fang Li et al.

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2020)

Add to Collection

Review Medicine, General & Internal

Immunology and ovarian cancers

Wen-Ling Lee et al.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2020)

Add to Collection

Review Medicine, General & Internal

Severe acute respiratory syndrome coronavirus-2 and the deduction effect of angiotensin-converting enzyme 2 in pregnancy

Yu-Ju Lai et al.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2020)

Add to Collection

Review Medicine, General & Internal

Immunological aspects of coronavirus disease during pregnancy: an integrative review

Camila Radelley Azevedo Costa da Silva et al.

REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2020)

Add to Collection

Review Medicine, General & Internal

A review of severe acute respiratory syndrome coronavirus 2 infection in the reproductive system

Hsin-Hui Huang et al.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2020)

Add to Collection

Review Medicine, General & Internal

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis

John Allotey et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Add to Collection

Article Medicine, General & Internal

Clinical manifestation and disease progression in COVID-19 infection

Ping-Hsing Tsai et al.

Journal of the Chinese Medical Association (2020)

Add to Collection

Article Medicine, General & Internal

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

Maheshi N. Ramasamy et al.

LANCET (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020

Laura D. Zambrano et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Add to Collection

Editorial Material Medicine, General & Internal

Aberrant sialylation of immune cells in rheumatoid arthritis

Wen-Ling Lee et al.

JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2019)

Add to Collection

Review Obstetrics & Gynecology

Immunizations during pregnancy: How, when and why

Alexandros Psarris et al.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2019)

Add to Collection

Article Obstetrics & Gynecology

Maternal Immunization

Flor M. Munoz et al.

OBSTETRICS AND GYNECOLOGY (2019)

Add to Collection

Review Medicine, General & Internal

The Role of Progesterone in Feto-Maternal Immunological Cross Talk

Julia Szekeres-Bartho

MEDICAL PRINCIPLES AND PRACTICE (2018)

Add to Collection

Article Pharmacology & Pharmacy

Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage

Paul Ndaya-Oloo et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2018)

Add to Collection

Article Obstetrics & Gynecology

Emerging Infectious Diseases in Pregnancy

Richard H. Beigi

OBSTETRICS AND GYNECOLOGY (2017)

Add to Collection

Article Obstetrics & Gynecology

Is birth cohort 1985/9-1990/8 a susceptibility window for congenital rubella syndrome in Taiwan?

Chen-Li Lin et al.

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2016)

Add to Collection

Article Immunology

AS03B-Adjuvanted H5N1 Influenza Vaccine in Children 6 Months Through 17 Years of Age: A Phase 2/3 Randomized, Placebo-Controlled, Observer-Blinded Trial

Pope Kosalaraksa et al.

JOURNAL OF INFECTIOUS DISEASES (2015)

Add to Collection

Review Immunology

Safety of immunization during pregnancy: A review of the evidence of selected inactivated and live attenuated vaccines

Brigitte Keller-Stanislawski et al.

VACCINE (2014)

Add to Collection

Article Obstetrics & Gynecology

Increased concentration of sialidases by HeLa cells might influence the cytotoxic ability of NK cells

Wen-Chi Lee et al.

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2012)

Add to Collection

Article Obstetrics & Gynecology

Altered ganglioside GD3 in HeLa cells might influence the cytotoxic abilities of NK cells

Wen-Chi Lee et al.

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2012)

Add to Collection

© Peeref 2019-2024. All rights reserved.